These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
689 related items for PubMed ID: 24014598
21. Oral contraception and cancer of the female reproductive system. Woods KL. J Clin Hosp Pharm; 1985 Jun; 10(2):123-35. PubMed ID: 3894428 [Abstract] [Full Text] [Related]
23. Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports. Hawley W, Nuovo J, DeNeef CP, Carter P. J Am Board Fam Pract; 1993 Mar; 6(2):123-35. PubMed ID: 8452064 [Abstract] [Full Text] [Related]
24. Contraception and the big "C". Chandran R. Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024 [Abstract] [Full Text] [Related]
26. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Kay CR. Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858 [Abstract] [Full Text] [Related]
27. Researchers can now investigate long-term effects of OCs on cancer. Rubin GL, Peterson HB. Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918 [Abstract] [Full Text] [Related]
29. Update on cancer control in women. Boyle P, Maisonneuve P, Autier P. Int J Gynaecol Obstet; 2000 Aug; 70(2):263-303. PubMed ID: 10960611 [Abstract] [Full Text] [Related]
30. Cancer risks of oral contraception. Lancet; 1989 Jan 07; 1(8628):21-2. PubMed ID: 2563004 [Abstract] [Full Text] [Related]
31. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis. Fitzpatrick D, Pirie K, Reeves G, Green J, Beral V. PLoS Med; 2023 Mar 07; 20(3):e1004188. PubMed ID: 36943819 [Abstract] [Full Text] [Related]
32. Family history and risk of endometrial cancer: a systematic review and meta-analysis. Win AK, Reece JC, Ryan S. Obstet Gynecol; 2015 Jan 07; 125(1):89-98. PubMed ID: 25560109 [Abstract] [Full Text] [Related]
34. Health outcomes associated with use of hormonal contraception: breast cancer. Schneyer R, Lerma K. Curr Opin Obstet Gynecol; 2018 Dec 07; 30(6):414-418. PubMed ID: 30239373 [Abstract] [Full Text] [Related]
36. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. Moorman PG, Havrilesky LJ, Gierisch JM, Coeytaux RR, Lowery WJ, Peragallo Urrutia R, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. J Clin Oncol; 2013 Nov 20; 31(33):4188-98. PubMed ID: 24145348 [Abstract] [Full Text] [Related]
37. Risk of cancer with combined oral contraceptive use among Iranian women. Vaisy A, Lotfinejad S, Zhian F. Asian Pac J Cancer Prev; 2014 Nov 20; 15(14):5517-22. PubMed ID: 25081657 [Abstract] [Full Text] [Related]
38. Neoplastic effects of oral contraceptives. Grimes DA. Int J Fertil; 1991 Nov 20; 36 Suppl 1():19-24. PubMed ID: 1678377 [Abstract] [Full Text] [Related]
39. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. Kaunitz AM. J Reprod Med; 1996 May 20; 41(5 Suppl):419-27. PubMed ID: 8725705 [Abstract] [Full Text] [Related]
40. [Combined oral contraception and the risk of reproductive organs cancer in women]. Medard M L, Ostrowska L. Ginekol Pol; 2007 Aug 20; 78(8):637-41. PubMed ID: 18050614 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]